InvestorsHub Logo
Followers 523
Posts 6631
Boards Moderated 1
Alias Born 07/24/2012

Re: None

Wednesday, 10/10/2012 10:31:19 PM

Wednesday, October 10, 2012 10:31:19 PM

Post# of 130503
From a January PR and they have chosen Amarantus after 10 months of searching.....They must see the BIG picture and the Breakthrough Amarantus has discovered and now is going to develop

RBCC Seeks Out the Next Big Bioscience Breakthrough
Print
Alert
Rainbow Coral Corp (OTCBB:RBCC)
Historical Stock Chart

1 Year : From Oct 2011 to ChartsOct 2012
Click Here for more Rainbow Coral Corp .

Rainbow BioSciences, a division of Rainbow Coral Corp. (OTCBB: RBCC), is staying connected in the center of advanced bio-research in Houston.

To spearhead these efforts, RBCC attended a breakfast forum, hosted by BioHouston--one of the nation’s preeminent drivers of life sciences research and commercialization. Events such as these enable the Company to meet with the potential developers of the next breakthrough in bioscience research and get involved at the ground level.

RBCC works with early stage biotech entities that may hold the key to the next big advances in bioscience discoveries. Companies such as Advanced Cell Technology, Inc. are developing cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. Connecting with forward-thinking and innovative leaders like Advanced Cell Technology could help RBCC develop and market the next big breakthrough in the industry.

Houston, TX is a recognized as an incubation hub for bioscience research and technology and is home to the world’s largest medical complex. RBCC will continue to attend Houston-based events to further solidify its place as a source for leading-edge bioscience initiatives.

For more information on Rainbow BioSciences, Rainbow Coral’s biotech division, please visit www.rainbowbiosciences.com/investors.

Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Amgen Inc. (NASDAQ: AMGN), Biogen Idec, Inc. (NASDAQ: BIIB), Gilead Sciences, Inc. (NASDAQ: GILD) and Life Technologies Corporation (NASDAQ: LIFE).